UHC/CWRU ADRC COMPETITIVE RENEWAL
UHC/CWRU ADRC 竞争性更新
基本信息
- 批准号:2049992
- 负责人:
- 金额:$ 206.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-09-21 至 1998-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In its first four years of existence, our NIA ADRC has developed as a
broad based research enterprise with major, local and national impact.
Our proposal includes the four required cores: Administrative, Clinical,
Neuropathology, Research Training and Information Transfer (RTIT). In
addition to our existing Patient Registry and Data Management Analysis
Components, our clinical core has grown with the recent competitively
funded additions of a Psychopathology Assessment Component and NIA
Satellite ADRC. Moreover, we have added an NIA funded Caregiver Core
that provides data for clinical and social research on characteristics of
the caregivers of our patents. Our RTIT core has expanded with
competitive funding and considerable involvement from the local and
national Alzheimer's Association. In this new application, six research
projects are included. Two basic biological studies involve new,
recently recruited senior faculty members in our center: G. Landreth the
relationship between amyloid and glia; and K. Herrup on transgenic animal
models of Alzheimer's disease (AD). Two other new projects involve C.
Gilmore, studying the cognitive basis of visual disturbances in AD and D.
Ripich evaluating communication in minority and nonminority caregivers;
M. Patterson is leading efforts to characterize the behavioral symptoms
of AD and K. Smyth is leading efforts in the use of services of
caregivers with strong linkages to our two new cores. Our strong pilot
program continues. Of over 50 faculty and other senior investigators
involved with our AD research efforts at the University, many were
introduced to the field through the pilot program. The renewal pilots as
similarly broad in scope as our research projects ranging from basic
biology (S. Younkin, amyloid processing) to clinical (J. Fagan, visual
attention and K. Smyth, insight and denial of illness). Our proposed
expansion of the NIA ADRC will allow us to continue our leadership role
in the rapidly advancing national and international efforts to understand
AD and improve the quality of lives of its victims.
在成立的头四年里,我们的NIA ADRC已经发展成为一个
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER John WHITEHOUSE其他文献
PETER John WHITEHOUSE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER John WHITEHOUSE', 18)}}的其他基金
MEDICAL GOALS IN DEMENTIA: ETHICS & QUALITY OF LIFE
痴呆症的医疗目标:伦理
- 批准号:
6266733 - 财政年份:2001
- 资助金额:
$ 206.28万 - 项目类别:
MEDICAL GOALS IN DEMENTIA: ETHICS & QUALITY OF LIFE
痴呆症的医疗目标:伦理
- 批准号:
6533840 - 财政年份:2001
- 资助金额:
$ 206.28万 - 项目类别:
MEDICAL GOALS IN DEMENTIA: ETHICS & QUALITY OF LIFE
痴呆症的医疗目标:伦理
- 批准号:
6644767 - 财政年份:2001
- 资助金额:
$ 206.28万 - 项目类别:
MEDICAL GOALS IN DEMENTIA: ETHICS & QUALITY OF LIFE
痴呆症的医疗目标:伦理
- 批准号:
6937661 - 财政年份:2001
- 资助金额:
$ 206.28万 - 项目类别:
MEDICAL GOALS IN DEMENTIA: ETHICS & QUALITY OF LIFE
痴呆症的医疗目标:伦理
- 批准号:
6783306 - 财政年份:2001
- 资助金额:
$ 206.28万 - 项目类别:
UHC/CWRU ALZHEIMERS DISEASE RESEARCH CENTER
UHC/CWRU 阿尔茨海默病研究中心
- 批准号:
3566797 - 财政年份:1988
- 资助金额:
$ 206.28万 - 项目类别:
UHC/CWRU ALZHEIMERS DISEASE RESEARCH CENTER
UHC/CWRU 阿尔茨海默病研究中心
- 批准号:
3104856 - 财政年份:1988
- 资助金额:
$ 206.28万 - 项目类别:
相似国自然基金
车载中央计算平台软件框架及泊车功能研发与产业化应用
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
低空飞行器及其空域的设计与监管平台软件
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于金刚石高效散热封装的高功率高压GaN器件研发与产业化
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
新能源智能汽车高性能精密零部件装备研制与产业化
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
高效智能化超低风速风电机组关键技术及装备研制
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
绿氢制储加注关键技术与装备研发
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
复杂电子产品超精密加工及检测关键技术研究与应用
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
抗消化性溃疡新药研发
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于合成生物学的动物底盘品种优化及中试应用研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
1.1 类中药创新药“鱼酱排毒合剂”开发
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 206.28万 - 项目类别:
Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 206.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 206.28万 - 项目类别:
Research Grant
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 206.28万 - 项目类别:
Continuing Grant
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
- 批准号:
478226 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Operating Grants
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
- 批准号:
495662 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Operating Grants
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
- 批准号:
23K06058 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Computational modelling of disease progression and subtype discovery in Alzheimer's Disease
阿尔茨海默病疾病进展和亚型发现的计算模型
- 批准号:
2885305 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Studentship
The Contribution of Mitochondrial Dysfunction to Alzheimer's disease
线粒体功能障碍对阿尔茨海默病的影响
- 批准号:
2886872 - 财政年份:2023
- 资助金额:
$ 206.28万 - 项目类别:
Studentship